• Predictive AI-driven maternity care modeling for CALD women underway
• Accelerated timeline for AI Clinician Assistant with initial releases in Q4 CY25
• New AI Virtual Companion for advanced women's health assistance
• Expanded Bluetooth and cellular device integrations for remote monitoring
• Customer-led upgrades to HeraCARE with AI-powered analytics

HeraMED Limited, a leader in maternity care and digital women's health, is pleased to announce its decision to accelerate the development and deployment of its AI-driven technologies and key product roadmap initiatives for the HeraCARE platform. This acceleration has been implemented in partnership with key existing customers as well as advanced pipeline customers with the critical strategic support from the company's advisory board. HeraMED is executing a multi-layered strategy designed to improve clinical outcomes, streamline workflows, and support scalable adoption of digital maternity care and women's health solutions globally. The company's technology roadmap includes the development of a new ambient scribe tool that leverages AI to automatically generate structured consultation notes during virtual telehealth appointments, reducing administrative burden for clinicians and improving documentation accuracy. HeraMED has also accelerated the development of its AI Clinician Assistant, with the first version releasing in Q4 2025, which will include automated notes and workflow support. Additionally, the company has kicked off a project with the Digital Health Cooperative Research Centre (CRC) and RMIT University to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse (CALD) populations. HeraMED is also developing a women's health message-based companion to empower patient engagement and support healthcare administrative staff efficiency. The company is also advancing its EMR/EHR interoperability to enable seamless integration with major healthcare solutions, and expanding its connected devices ecosystem to include Bluetooth and cellular-based devices for a broader range of lifestyle and clinical monitoring. Finally, HeraMED is driving customer-led innovation in AI-powered features within the HeraCARE analytics dashboard to provide healthcare teams with deeper and quicker insights into patient engagement, compliance, and clinical outcomes.

HeraMED is accelerating the development and deployment of its AI-driven technologies and key product roadmap initiatives for the HeraCARE platform, including predictive AI modeling, AI clinician assistants, virtual companions, expanded device integrations, and customer-led analytics upgrades. These advancements will continue to position HeraMED as a leading solution for clinician-grade remote monitoring in women's health and provide capability for scalable long-term growth.